Home
CapitalBio Technology

CapitalBio Technology Market Share Analysis for August 2026

北京博奥晶典生物技术有限公司（以下简称“博奥晶典”）是博奥生物集团有限公司暨生物芯片北京国家工程研究中心的产业化平台，是清华大学布局生命健康领域的核心企业。博奥晶典注册成立于2012年8月，在北京、上海、重庆、成都、东莞、香港与美国圣地亚哥等地，拥有生物芯片和仪器设备的生产、研发基地和营销、运营中心，总办公面积超过15万㎡，员工2000余人。

Science and Education > Biology

Domaincapitalbiotech.com

Year Founded2000

Employees501 - 1000

Annual Revenue--

CapitalBio Technology

CapitalBio Technology (including company regionals)

capitalbiotech.com

See more website traffic and engagement information

Total visits to CapitalBio Technology's top domains

Understand CapitalBio Technology market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

capitalbiotech.com261

See more with Sales Intelligence

Avg. visit duration in CapitalBio Technology's top domains

Analyze CapitalBio Technology engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

capitalbiotech.com--

See more with Sales Intelligence

Avg. pageviews on CapitalBio Technology's top domains

See how CapitalBio Technology keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

capitalbiotech.com1.07

See more with Sales Intelligence

CapitalBio Technology top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by CapitalBio Technology

These are the website technologies, by industry, used by CapitalBio Technology top domains

Advertising (2)

PubMatic

Content Management System (2)

WordPress

Conversion & Analytics (1)

Baidu Analytics

Mobile (1)

Meta Viewport

More Technologies

2

See all

News & Signals from CapitalBio Technology

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCapitalbiotech receives financing of $113M in financing.CapitalBio Tech, a Beijing molecular diagnostics product and service company, completed a $113 million funding to prepare for a listing on Shanghai's STAR Exchange.